Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

46.680
-0.820-1.73%
Volume:14.84M
Turnover:694.24M
Market Cap:194.00B
PE:34.42
High:47.500
Open:47.500
Low:46.160
Close:47.500
52wk High:54.450
52wk Low:28.480
Shares:4.16B
HK Float Shares:4.16B
Volume Ratio:1.16
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.356
ROE:11.38%
ROA:7.60%
PB:3.45
PE(LYR):34.42
PS:7.03

Loading ...

Movement Alert|WuXi Biologics Rises 3.35% in Regular Trading, Pharma Sector Buyback Wave Boosts Market Confidence

Market Focus
·
Jun 18

CANbridge Pharmaceuticals Enters Service Agreements With WuXi Biologics, Baheal Medical

MT Newswires Live
·
Jun 17

WuXi XDC unit BioDlink wins RMB 19 million process development, manufacturing order from WuXi Biologics

Reuters
·
Jun 17

CANbridge signs WuXi Biologics CRDMO services framework agreement with RMB 39.8 million 2026 cap

Reuters
·
Jun 16

Wuxi Biologics (Cayman) Stock Falls 2.9% in Hong Kong

Dow Jones
·
Jun 16

Movement Alert|WuXi Biologics Falls 3.04% in Regular Trading, Weighed by Geopolitical Headwinds After Affiliate Listed on US Defense Blacklist

Market Focus
·
Jun 16

WuXi Biologics (SEHK:2269) Stock After Regulatory Jitters And A 76.5% Five Year Slide

Simply Wall St.
·
Jun 13

WUXI BIO Executes HK$99.8 Million Share Buyback on June 12

Stock News
·
Jun 12

WuXi Biologics files HKEX next-day return, share capital rises by 21,000 shares

Reuters
·
Jun 12

Wuxi Biologics (Cayman) Stock Climbs 3.8% in Hong Kong

Dow Jones
·
Jun 12

Movement Alert|WuXi Biologics Rises 3.21% in Regular Trading, Aggressive Buyback Program and Sector Rebound Drive Recovery

Market Focus
·
Jun 12

WuXi Biologics makes S&P Global Sustainability Yearbook China edition for fourth straight year

Reuters
·
Jun 11

WUXI BIO issues 1.48 million new shares on option exercise and buys back 3.39 million shares under new mandate

Bulletin Express
·
Jun 11

WUXI BIO Executes Share Buyback, Spending Nearly HK$100 Million on June 11th

Stock News
·
Jun 11

Movement Alert|WuXi Biologics Falls 4.21% in Regular Trading, Continued Pressure from US Regulatory Actions Against WuXi Group

Market Focus
·
Jun 10

WUXI BIO completes HK$74.88 million share buyback, lifting pending cancellations to 21.10 million shares

Bulletin Express
·
Jun 09

WUXI BIO Executes Share Buyback, Spending HK$74.9 Million on June 9

Stock News
·
Jun 09

WuXi Biologics files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 09

WUXI BIO Grants 288,400 Restricted Shares

Stock News
·
Jun 09

Wuxi Biologics (Cayman) Stock Sheds 1.4% in Hong Kong

Dow Jones
·
Jun 09